UiPath Inc. (NYSE:PATH - Get Free Report) rose 1.7% during mid-day trading on Thursday . The stock traded as high as $13.05 and last traded at $12.92. Approximately 1,540,216 shares traded hands during trading, a decline of 84% from the average daily volume of 9,586,992 shares. The stock had previously closed at $12.71.
Analysts Set New Price Targets
A number of brokerages have weighed in on PATH. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $16.00 price objective on shares of UiPath in a report on Friday, December 6th. BMO Capital Markets upped their price objective on UiPath from $15.00 to $16.00 and gave the stock a "market perform" rating in a report on Friday, December 6th. DA Davidson increased their price objective on UiPath from $13.00 to $15.00 and gave the stock a "neutral" rating in a research report on Friday, September 6th. Morgan Stanley boosted their target price on shares of UiPath from $15.00 to $16.00 and gave the stock an "equal weight" rating in a research report on Friday, December 6th. Finally, UBS Group started coverage on shares of UiPath in a report on Thursday, December 12th. They issued a "sell" rating and a $14.00 price target for the company. One investment analyst has rated the stock with a sell rating, sixteen have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $17.50.
View Our Latest Stock Analysis on PATH
UiPath Stock Up 1.7 %
The firm has a market cap of $7.11 billion, a price-to-earnings ratio of -80.81 and a beta of 0.94. The firm has a fifty day moving average price of $13.45 and a 200-day moving average price of $12.69.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently modified their holdings of the stock. Cowa LLC increased its position in UiPath by 4.4% during the third quarter. Cowa LLC now owns 26,681 shares of the company's stock worth $342,000 after purchasing an additional 1,118 shares during the last quarter. Nations Financial Group Inc. IA ADV increased its holdings in shares of UiPath by 6.8% during the 3rd quarter. Nations Financial Group Inc. IA ADV now owns 26,090 shares of the company's stock worth $334,000 after buying an additional 1,654 shares during the last quarter. Amalgamated Bank raised its position in shares of UiPath by 7.1% in the 3rd quarter. Amalgamated Bank now owns 27,312 shares of the company's stock worth $350,000 after buying an additional 1,811 shares during the period. Thrivent Financial for Lutherans grew its position in UiPath by 10.6% during the third quarter. Thrivent Financial for Lutherans now owns 20,881 shares of the company's stock valued at $267,000 after acquiring an additional 1,995 shares during the period. Finally, Future Financial Wealth Managment LLC purchased a new stake in UiPath during the third quarter valued at about $26,000. Institutional investors and hedge funds own 62.50% of the company's stock.
About UiPath
(
Get Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Featured Stories
Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.